Briacell Therapeutics
BCTX
8 hedge funds and large institutions have $1.45M invested in Briacell Therapeutics in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.04% more ownership
Funds ownership: 0% → 0.04% (+0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$581K |
| 2 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
+$478K |
| 3 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
+$163K |
| 4 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$59.3K |
| 5 |
VF
Virtu Financial
New York
|
+$54.9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $618K | +$581K | +1,068 | New |
|
|
RAM
2
Redmond Asset Management
Henrico,
Virginia
| $508K | +$478K | +878 | New |
|
|
ZCA
3
Zeke Capital Advisors
Berwyn,
Pennsylvania
| $174K | +$163K | +300 | New |
|
|
FIM
4
Freedom Investment Management
Hartford,
Connecticut
| $63K | +$59.3K | +109 | New |
|
|
VF
5
Virtu Financial
New York
| $58K | +$54.9K | +101 | New |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $23K | +$21.8K | +40 | New |
|
7
UBS Group
Zurich,
Switzerland
| $2K | +$2.17K | +4 | New |
|
|
HI
8
Harbour Investments
Madison,
Wisconsin
| $1K | +$544 | +1 | New |
|
BCTX Hedge Fund Activity: Q1 2021 in Review
8 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Briacell Therapeutics (BCTX) for Q1 2021, worth a combined $1.45M.
Buyers outnumbered sellers: 8 funds opened new BCTX positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $581K.
- 8 institutional investors held Briacell Therapeutics (BCTX) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $1.45M of Briacell Therapeutics stock for Q1 2021.
- 8 funds opened new Briacell Therapeutics positions in Q1 2021 and 0 closed out, a net change of +8 holders.
- The largest Briacell Therapeutics buyer in Q1 2021 was Sabby Management, an estimated $581K added.
Based on aggregated 13F filings for Q1 2021.